Does USTEKINUMAB Cause Hepatic enzyme increased? 3,797 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,797 reports of Hepatic enzyme increased have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 4.5% of all adverse event reports for USTEKINUMAB.
3,797
Reports of Hepatic enzyme increased with USTEKINUMAB
4.5%
of all USTEKINUMAB reports
1,496
Deaths
1,891
Hospitalizations
How Dangerous Is Hepatic enzyme increased From USTEKINUMAB?
Of the 3,797 reports, 1,496 (39.4%) resulted in death, 1,891 (49.8%) required hospitalization, and 1,769 (46.6%) were considered life-threatening.
Is Hepatic enzyme increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 3,797 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
TOFACITINIB (6,269)
Which USTEKINUMAB Alternatives Have Lower Hepatic enzyme increased Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE